Replies to post #245069 on Biotech Values

[mouton29]

<<As far as EDP-235, it is a different chemical entity than Paxlovid so it is highly unlikely any mutants resistant to it will exhibit cross-resistance to EDP-235.>>

Indeed, that was my assumption and partly for that reason I added to my ENTA position today.